Update of application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders
Open Access
- 10 January 2022
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 13 (1) , 1-14
Abstract
Age-related macular degeneration, diabetic retinopathy, retinitis pigmentosa and other retinal disorders are the main causes of visual impairment worldwide. In the past, these retinal diseases, especially dry age-related macular degeneration, proliferative diabetic retinopathy and retinitis pigmentosa, were treated with traditional surgery and drugs. However, the effect was moderate. In recent years, researchers have used embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, olfactory ensheathing cells and other stem cells to conduct experiments and found that stem cells can inhibit inflammation, regulate immune response, secrete neurotrophic factors, and differentiate into retinal cells to replace and promote restoration of the damaged parts. These stem cells have the potential to treat retinal diseases. Whether it is in animal experiments or clinical trials, the increase in the number of retinal cells, maintenance of function and improvement of visual function all reflect the advanced of stem cells to treat retinal diseases, but its risk preserves the donor’s hidden pathogenic genes, immune rejection and tumorigenicity. With the development of exosomes study, researchers have discovered that exosomes come from a wide range of sources and can be secreted by almost all types of cells. Using exosomes with stem cell to treat retinal diseases is more effective than using stem cells alone. This review article summarizes the recent advances in the application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders.Keywords
Funding Information
- National Natural Science Foundation of China (81970791)
- Science and Technology Bureau of Quanzhou (2020CT003)
This publication has 142 references indexed in Scilit:
- Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic LandmarksMediators of Inflammation, 2013
- Cell-Based Therapies for Diabetic RetinopathyCurrent Diabetes Reports, 2011
- Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal NeovascularizationJournal of Biological Chemistry, 2011
- Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transectionExperimental Neurology, 2011
- Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbitsInternational Journal of Experimental Pathology, 2011
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMDExperimental Eye Research, 2009
- Induced Pluripotent Stem Cells Generated Without Viral IntegrationScience, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient miceNature Medicine, 2003